Eric Singhi, MD, discusses the key milestone that will be celebrated at the conference, which will be held in San Diego. Lurbinectedin monotherapy is currently being studied in Jazz EMERGE 402 study in patients with metastatic SCLC. Patients with autoimmune diseases—including rheumatoid arthritis (RA)—do not have poorer lung cancer survival ...